Macro Tsimmis

intelligently hedged investment

Dendreon (DNDN) update #8—Intelligent debate on Provenge

Posted by intelledgement on Thu, 12 Apr 07

If you have been following the trials and tribulations of Dendreon, a speculative biotech play in our ISOP portfolio, then you might want to check a Provenge (Dendreon’s immuno therapy product for prostate cancer with the FDA are presently reviewing for possible approval) post on the Investor Village DNDN board by an intelligent and articulate bear. He cogently explains most of the serious concerns, both pre-approval and post-approval (which are the more salient issues at this point, in our opinion).

Be sure to peruse some of the replies, but at least those by croumagnon, fordwill1953, and most especially rancherho (this last being one of the best posts we have ever seen on any stock message board).


Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: